All Clinical Trials

< Back to search

Filter

Filter results

Results: 22,345

Chemotherapy ReductionPersonalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma

Recruiting

PHASE2

Sponsor:

University of Washington

Location:

Seattle WA

Code:

NCT06745076

Conditions

Advanced Hodgkin Lymphoma

Classic Hodgkin Lymphoma

Lugano Classification Stage III Hodgkin Lymphoma AJCC v8

Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Dacarbazine

Doxorubicin

Echocardiography

High-Protein Supplement with Liposomal CurcuminHigh-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis.

Recruiting

PHASE3

Sponsor:

University of Florida

Location:

Gainesville FL

Code:

NCT06381076

Conditions

Chronic Kidney Disease 5D

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Liposomal curcumin

Food colorant

Beta BlockerCSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

Recruiting

PHASE3

Sponsor:

VA Office of Research and Development

Location:

Boston MA, Minneapolis MN, New York NY

Code:

NCT05931276

Conditions

End-Stage Kidney Disease

End-Stage Renal Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Metoprolol Succinate

Carvedilol

ImagingCollagen-targeted PET Imaging for Early Interstitial Lung Disease

Recruiting

PHASE2

Sponsor:

Massachusetts General Hospital

Location:

Boston MA

Code:

NCT05417776

Conditions

Interstitial Lung Disease

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

[68Ga]CBP8

Dotarem

Enstilar & EnbrelEnstilar in Combination With Enbrel or Humira for Plaque Psoriasis

Recruiting

Sponsor:

Psoriasis Treatment Center of Central New Jersey

Location:

East Windsor NJ

Code:

NCT03827876

Conditions

Psoriasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Enstilar 0.005%-0.064% Topical Foam

Observational StudyReading Remediation and Outcomes in Detention

Recruiting

Sponsor:

Baylor College of Medicine

Location:

Houston TX

Code:

NCT03261076

Conditions

Specific Learning Disorder (MeSH Unique ID: D000067559)

Dyslexia (MeSH Unique ID: D004410)

Conduct Disorder (MeSH Unique ID: D019955)

Eligibility Criteria

Sex: Male

Age: 14 - 16

Healthy Volunteers: Not accepted

Interventions

Strategies Enhancing Reading in Older Underperf. Students

Lomustine with Temozolomide & RadiationTesting the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Fairbanks AK, Fayetteville AR, Little Rock AR, Rogers ARshow 269 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Magnetic Resonance Imaging

Photon Beam Radiation Therapy

Questionnaire Administration

Temozolomide

Mezigdomide & CarfilzomibA Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

Recruiting

PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Mobile AL, Cerritos CA, Irvine CA, Los Angeles CAshow 34 more

Code:

NCT05552976

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Mezigdomide

Carfilzomib

Dexamethasone

KetorolacLow-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients

Recruiting

Sponsor:

Massachusetts General Hospital

Location:

Boston MA, Nashville TN

Code:

NCT06201676

Conditions

Orthopaedic Polytrauma

Chronic Opioid Use

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Ketorolac Injection

Normal Saline

Metabolic ImagingDeveloping a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

Recruiting

Sponsor:

OHSU Knight Cancer Institute

Location:

Portland OR

Code:

NCT05937776

Conditions

Glioma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Fludeoxyglucose F-18

Gadoterate Meglumine

Contrast-enhanced Magnetic Resonance Imaging

Positron Emission Tomography